HMC showcases world-class dermatology services in ‘Your Health, Our Priority' drive

Qatar Tribune

06-05-2025

Hanane Djoua
Doha
As part of its ongoing Your Health, Our Priority campaign, Hamad Medical Corporation (HMC) has spotlighted its Dermatology and Venereology Department — a regional hub of excellence in skin health that continues to gain global recognition for innovation, research, and specialised care.
HMC's Dermatology Department delivers high-quality, personalised treatment for patients of all ages and conditions — ranging from eczema, psoriasis, vitiligo, and alopecia to skin cancer, rare genetic disorders, and complex autoimmune diseases.
The department also stands at the forefront of technological advancement and multidisciplinary research in dermatology.
'Our dermatology services reflect HMC's broader commitment to delivering specialised, world-class healthcare to the community of Qatar,' said Prof Martin Steinhoff, chairman of HMC's Dermatology and Venereology Department.
Ranked among the top two percent of researchers worldwide by Stanford University, Prof Steinhoff emphasised the department's capacity to address both common and rare skin disorders with the most updated and tailored therapies.
In an interview with Qatar Tribune, Prof Steinhoff said, 'Our department is the largest of its kind in Qatar and among the most advanced in the region. With over 14 sub-specialty clinics, we see more than 300 patients a day and cover the full spectrum of dermatologic services — from medical and surgical dermatology to advanced therapies for genetic and autoimmune skin diseases.'
Among the key services offered are:
• Biologic and immunomodulatory therapies for inflammatory skin diseases;
• Advanced laser treatments for pigmentation, scarring, and rosacea;
• Dermato-surgery for skin biopsies and cancer excisions;
• Hair and scalp clinics for alopecia and related disorders;
• Light-based therapies for conditions such as cutaneous T-cell lymphoma;
• Paediatric and geriatric dermatology clinics — the latter being one of the first worldwide;
• Genetic dermatology for rare genodermatoses and haemangiomas;
• Sclerotherapy and foam sclerotherapy for varicose and spider veins.
'The integration of real-time skin imaging, dermoscopy, and ultrasound in our diagnostics enables earlier, more precise detection of life-threatening conditions like melanoma and scleroderma,' Dr Steinhoff noted, adding that emergency care for severe skin conditions such as Stevens-Johnson Syndrome, drug allergies, and erythroderma is also part of their specialty.
Commenting on the department's international vision, he shared, 'We are now developing aesthetic dermatology as a future service and are consistently adopting the latest minimally invasive treatments and biologic medications. Our mission is to bring the same level of care that patients would receive in leading centres like New York or Berlin — right here in Qatar.'
Prof Steinhoff also revealed that the Dermatology Department offers an American-accredited residency program, ensuring that Qatari-trained dermatologists receive an education aligned with international standards.
'From day one, our residents follow a rigorous curriculum equivalent to what they would experience in the US or Germany. We host educational workshops, collaborate with global experts, and constantly bring international knowledge into Qatar,' he said.
Dr Ayda Al Hammadi, senior consultant at the department, echoed this vision, saying, 'Our goal is not only to treat but to set new global standards in dermatological care.'
Dr Sara Al Khawaga, specialist in dermatology, emphasised the blend of compassionate care and scientific progress, noting, 'We ensure every patient receives the most effective, evidence-based treatment.'
Dr Aysha Al Malki, director of the Dermatology Residency Programme, said: 'Our strength lies in combining research, education, and clinical excellence. Through this, we continue to build a future-ready, world-class dermatology service in Qatar.'